Yara Alyahyawi: Advancing Epigenetic Therapy for Hemophilia B
Yara Alyahyawi, Assistant Professor at Jazan University and PhD researcher at University of Birmingham, shared a post on LinkedIn about a recent article she and T. M. Belali co-authored, published in Molecular Biology, adding:
“Thank God, our scientific paper entitled
Epigenetic Reactivation of F9 via HNF4α as a Therapeutic Strategy for Hemophilia B
Using the In Silico model, the research explores the possibility of enhancing F9 gene expression through HNF4α and CRISPR-based epigenetic activation as a promising research strategy for Hemophilia B.
I was honored to be the first author and corresponding author in this work.”
Title: Epigenetic Reactivation of F9 via HNF4α as a Therapeutic Strategy for Hemophilia B
Authors: Y. Alyahyawia, and T. M. Belali
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 18, 2026, 23:31Rana Al-Hrout: MAHA – More Than Schistocytes
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection